IMU 3.77% 5.1¢ imugene limited

Ann: Imugene Dose Escalates in PD1-VAXX Phase 1 Clinical Trial, page-303

  1. 2,736 Posts.
    lightbulb Created with Sketch. 1062

    I came across the following video this evening and I thought it was very good at explaining IMU's PD1 Vaxx product.
    I hadn't seen it before and thought it might offer people interested a good recap on why PD1 Vaxx is important.

    Imugene PD1 Vaxx
    7 July 2019

    Our PD-1 B-cell vaccine, known as PD1-Vaxx, aims to induce the body to produce polyclonal antibodies that block PD-1 signalling, and thus produce an anticancer effect similar to Keytruda, Opdivo and the other immune checkpoint inhibitor monoclonal antibodies, that have transformed treatment for a range of cancers. PD1-Vaxx has shown encouraging potential in preclinical studies, including outperforming an industry-standard mouse anti-PD-1 antibody in a mouse model of HER2+ colorectal cancer.

    Music in this video
    Song Science Artist Barinov Oleksandr (Beat-Hoven)
    Licensed to YouTube by HAAWK for a 3rd Party (on behalf of Beat-Hoven Productions); HAAWK Publishing


 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
5.1¢
Change
-0.002(3.77%)
Mkt cap ! $373.3M
Open High Low Value Volume
5.2¢ 5.2¢ 5.0¢ $669.7K 13.07M

Buyers (Bids)

No. Vol. Price($)
6 1074997 5.1¢
 

Sellers (Offers)

Price($) Vol. No.
5.2¢ 1209633 6
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.